1. Home
  2. WST vs GH Comparison

WST vs GH Comparison

Compare WST & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

N/A

Current Price

$414.40

Market Cap

27.9B

Sector

Health Care

ML Signal

N/A

Logo Guardant Health Inc.

GH

Guardant Health Inc.

N/A

Current Price

$155.55

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WST
GH
Founded
1923
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9B
22.9B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
WST
GH
Price
$414.40
$155.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
26
Target Price
★ $471.00
$200.88
AVG Volume (30 Days)
690.9K
★ 2.0M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 0.25%
N/A
EPS Growth
1.49
★ 6.74
EPS
★ 7.09
N/A
Revenue
★ $2,886,900,000.00
$982,021,000.00
Revenue This Year
$11.26
$39.22
Revenue Next Year
$5.92
$35.02
P/E Ratio
$58.45
★ N/A
Revenue Growth
1.95
★ 32.88
52 Week Low
$223.83
$74.55
52 Week High
$438.27
$191.05

Technical Indicators

Market Signals
Indicator
WST
GH
Relative Strength Index (RSI) 65.27 41.68
Support Level $326.40 $154.16
Resistance Level $438.27 $177.55
Average True Range (ATR) 11.68 10.26
MACD -0.14 -2.09
Stochastic Oscillator 52.87 39.85

Price Performance

Historical Comparison
WST
GH

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: